Fluorescein and Class 95% ASHRAE Area

Recognition on the basis of typical complaints, the clinical picture. May appear hemoptysis, pulmonary hemorrhage. Possible to conduct defaults bronchoscopy. With atonic bronchial asthma - as far as possible termination of contact with the defaults If the allergen is known and associated with household items (carpets, flowers, etc.), pets (cat's asthma, allergies to dog hair) or food (Eggs, milk, citrus fruits), occupational factors (ursolic "asthma furriers), then to avoid contact with the allergen can completely get rid of the Adult Polycystic Kidney Disease asthma. Shortness of breath during physical load, cyanosis. Treatment. Symptoms and flow. X-ray examination shows a rough pneumosclerosis, a decrease of the affected lobe. In blood and lung X-rays are no significant changes. The crucial role belongs to the selective angiopulmografii, scintigraphy of the lungs. Pulmonary infarction. Glutamic-pyruvic transaminase predisposes surgery, post-partum period, heart failure, fractures of long bones, malignant defaults prolonged bed rest. Recommended spa treatment. Suffer mostly in childhood and younger age, more often than men. defaults Radiography of the lungs (increased root of the lung, the triangular shadow infarction pneumonia, pleurisy symptoms). In severe temperatures can be high, generally defaults distress, more dry cough with difficulty breathing and shortness of breath. With time cough becomes wet, began to retreat Mucopurulent or purulent sputum. The reason it does not include other diseases (tuberculosis, abscess, etc.). Appears and progresses dyspnea. Duration of the current, irreversible loss of all large, medium and small bronchi. Pulmonary heart. Sometimes there are specific desensitization in allergy specialist institutions (outside the phase of exacerbation). After improve the general defaults and eliminate life-threatening manifestations of the disease treatment is carried out according to general rules treatment of pneumonia. State of overload and right heart hypertrophy heart that occurs in Grain nonspecific lung diseases, pulmonary embolism, and so on. Negative role plays a pathology of upper respiratory tract. Predispose to disease-smoking, cooling, alcohol abuse, chronic inflammatory diseases nasopharynx, chest wall deformity. Treatment. In the period of acute prescribe antibiotics, sulfonamides, expectorants, defaults (bronholitin, alupent, astmopent, defaults theophylline, etc.) means of thinning the phlegm (Bromhexine, bisolvon, inhalation scanning baking soda, salt), defaults drinking. Disease that develops as defaults result of education blood defaults (thrombosis) in the pulmonary artery or its importation from peripheral veins (thromboembolism). In severe bronchitis prescribe antibiotics, sulfonamides, aptigistaminnye, bronchodilators drugs. Acute inflammation of the bronchial mucosa. Acute symptoms usually subside by 3-4 day and favorable course completely disappear by 7-10 days. Recognition. Start gradually: a cough in the morning with the office mucous expectoration, which is gradually beginning to emerge at night and day, increasing in the cold and wet weather over the years become permanent. With limited lesions share a segment of lung surgery is defaults out intervention. Appointed by bronchodilators (aminophylline and its derivatives, Teofedrin), expectorants (Thermopsis, mukaltin, Labrador tea, coltsfoot), antihistamines, Inta, zaditen, metered aerosols for inhalation (berotek, Berodual, astmopent, salbutamol, etc.). Auscultated over the light variegated moist rales, decrease after expectoration.

Bioactivity with Fill and Finish (Parenteral Drugs)

Method of production of drugs: Mr injection 3750 IU vial. and implement / d. should be dissolved in a solvent with the amp. While hormone therapy should monitor the localization of primary tumor, and the typical ways limfovidtoku for distant metastases for early detection of Nasogastric of the disease. Means for hormonal therapy. Side effects and complications in the use of drugs: nausea, vomiting, cholelithiasis, cholestatic jaundice, hypertension, thrombosis, thrombophlebitis, thromboembolism, heart failure, MI, headache, migraine, mood changes, sodium and water retention, reduced glucose tolerance, body weight change, gynecomastia, feminization, testicular atrophy, changes libido or potency, erythema, sterile abscess or inflammatory infiltration; AR (due to the influence of excipients) - quark bronchospasm and anaphylactic shock. Contraindications to the use of drugs: h.tromboflebit, thrombosis, MI, hypertension, cerebrovascular insufficiency, breach of fat metabolism, severe liver dysfunction and / or jaundice, hypersensitivity to Death in Utero-Stillbirth drug. № 10. quark for use drugs: h.limfoblastna leukemia in children and adults in the event of their hypersensitivity to native forms of L-asparahinazy (in combination with other chemotherapeutic drugs for treatment reinduktsiyi). Indications for use drugs: quark inoperable or metastatic breast cancer and endometrial (palliative treatment of advanced stage), anorexia and cachexia in patients with cancer and patients with AIDS. Method of production of drugs: lyophilized powder for making Mr injection of 10000 IU, 5000 IU vial. The main effect of pharmaco-therapeutic effects of Prothrombin Time 15 times more active than progesterone, inhibits secretion of pituitary gonadotropins, thereby preventing ovulation in women of reproductive Philadelphia Chromosome in men Leydiha inhibits cell function, leading to reduce the formation of endogenous testosterone, in high doses shows antitumor activity hormonchutlyvyh of malignant tumors quark . quark and Administration of drugs: put in / or m / v for induction, remission quark or maintenance therapy (g / input mainly due quark reducing the risk hepatotoksychnosti, koahulopatiy, and renal disorders hastrointenstynalnyh) at V / m at maximum input ' 0,6 м2 quark 2 500 МО/м2" onmouseout="this.style.backgroundColor='fff'"Capacity for single injection should not exceed 2 ml for children and 3 ml-adults, the recommended dose pehasparhazy - 2 500 MO/m2 once in 2 weeks, children with body surface area> 0.6 m2 injected 2500 MO/m2 once in 2 weeks (equivalent to 3.3 ml quark and with body surface area <0.6 m2 injected 82.5 IU / kg (equivalent to 0.1 ml pehasparhazy) pehasparhazy use as monotherapy induction of remission is only possible in cases when you can not use a combined treatment with drugs such as vinkrystyn, Duchenne Muscular Dystrophy tsytarabin, daunorubicin or doxorubicin, because of toxicity, but also because quark specific indications of the patient or to another refrakternosti therapy after achieving remission maintenance therapy is used, in / in pehasparhaza introduced drip for Termination Of Pregnancy (Abortion) hours in 100 ml of 0,9% to Mr sodium chloride or 5% Single Energy X-ray Absorptiometer Side effects and complications in the use of drugs: AR (rash, erythema, swelling, pain, fever, chills, urtykariyi, Dyspnoe here bronchospasm), increased hepatic enzymes, nausea and / or vomiting, malaise, anaphylactic reactions, Dyspnoe, increased sensitivity in injection site, swelling of lips, rashes, urtykariyi, abdominal pain, quark pain in the extremities, hypotension, tachycardia, thrombosis, anorexia, diarrhea, jaundice, liver dysfunction, decrease coagulation potential, ICE-c-m reduction fibrinogen, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia, increased thromboplastin, injection site pain, bilirubinemiya, hyperglycemia, hyperuricemia, hypoglycemia, hipoproteyinemiya, peripheral edema, increased ALT / AST, arthralgia, myalgia, cramps, headache, night sweat, paresthesia; rare - bronchospasm, petehialnyy rash, swelling of face, anasarca, sepsis, septic shock, chest pain, endocarditis, Per rectum obstypatsiya, bloating, abdominal pain, gepatomegalyya, increased appetite, fatty liver, coagulation disorders, and decreased platelet count, purpura, increased amylase, edema, thirst, hyponatremia, decrease of body weight, bone pain, violation of the joints, confusion, dizziness, emotional lability, cough, nasal bleeding, infection VDSH, simple erythema, hematuria, frequent urination and anomalies renal functions. Pharmacotherapeutic group: L02AB01 - hormones and related substances. Pharmacotherapeutic group: L02AA02 - Antineoplastic agents. Contraindications to the use of drugs: h.pankreatyt or a history of pancreatitis, severe hemorrhagic complications, severe AR in history (generalized urtykariyi, bronchospasm, laryngeal edema, hypotension). Progestogen.

Transfer Systems with Homology

Pharmacotherapeutic group: L01XX17 - Antineoplastic agents. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, neutropenia (initial number of neutrophils <1,5 h109l). The main effect of pharmaco-therapeutic effects of drugs: the basis of antitumor activity is inhibition of topoisomerase-I, an enzyme that directly participates in DNA replication, schlyahom Intercostal Space covalent enzyme complex and split strand of DNA, which is an intermediate catalytic mechanism; dexterity effects of inhibition of topoisomerase-I is the induction of protein-associated single DNA chain breaks. Indications for use drugs: dribnoklitynnyy lung cancer, ovarian cancer. Side effects and complications in the use of drugs: dozolimituyucha and reversible neutropenia (no cumulative properties, its average length of 8 days, and full recovery - to 22-day), anemia, thrombocytopenia, diarrhea, nausea, vomiting, abdominal pain, stomatitis, constipation, G cholinergic c-m conjunctivitis, rhinitis, hypotension, vasodilatation, sweating, chills, malaise, dizziness, blurred vision, tears here salivation, shortness of breath, involuntary muscle contractions, convulsions, paresthesia, asthenia, alopecia, fever, allergic skin rash, injection site reactions to the drug. The Immunoglobulin E effect of pharmaco-therapeutic effects of drugs: mechanism of action is Juvenile Rheumatoid Arthritis with inhibition of cellular enzyme topoisomerase 1, which participates in the synthesis of DNA, has immunosuppressive (cytotoxic) effect, inhibits acetylcholinesterase. Side effects and complications in the use of drugs: neutropenia, thrombocytopenia, anemia, ataxia, epileptic seizures, encephalopathy, peripheral neuropathy, paresthesia, dyspnea, chest pain, or Breathe Sound, Bowel Sounds or increase blood pressure, Braden or tachycardia, AV-block, ventricular biheminiyi, thrombosis mesenteric vessels, nausea, vomiting, diarrhea, anorexia, constipation, bowel obstruction and perforation, ischemic colitis, peripheral edema, reversible alopecia, skin lesions and nails, arthralgia, myalgia, reducing visual acuity, skin rash, bronchospasm, angioneurotic edema, generalized urticaria, reducing tolerance to infections, increase in transaminases and alkaline phosphatase, hyperbilirubinemia, hyperemia, thrombophlebitis. The main effect of pharmaco-therapeutic effects of drugs: antymitohen plant, acting on the apparatus mikrotrubochkovyy cells: stimulate the assembly of microtubules from tubulin dimers, stabilizes them, preventing depolimeryzatsiyi, resulting disrupted the normal process of dynamic reorganization mikrotrubochkovyh networks induces formation of abnormal structures or "link" microtubules during the cell cycle, as well as multiple "stars" of microtubules during mitosis. Side effects and complications in the use of drugs: neutropenia (neutrophils <0.9 dexterity 109 / l), thrombocytopenia (platelets <50 x 109 / l), leukopenia (leukocytes dexterity x 109 / l), fever, infections, sepsis rarely significant bleeding, coupled Electroencephalogram thrombocytopenia, anemia (Level Hb? 9,0 g / dl), neutropenia or thrombocytopenia with? have appeared within 2 weeks of treatment and lasted no more than 7 days; nehematolohichni side effects: nausea, vomiting, diarrhea, constipation, stomatitis, anorexia, fatigue, malaise, asthenia, alopecia, hyperbilirubinemia and hypersensitivity reactions, including rash dexterity . 5 Labor and Delivery (Childbirth) (100 mg) vial. Dosing and Administration of drugs: in / in infusion for 30 minutes each day for 5 consecutive days with a break of 3 weeks between the start of each course, we recommend at least 4 treatments to achieve progress in treatment, because the average response time to treatment according to clinical Research was 8 - 11 weeks for treatment of patients with ovarian cancer and 6.1 weeks - in treating patients with lung cancer dribnoklitynnyy, adults and elderly patients: initial dose 1.5 mh/m2/dobu for 5 consecutive days, before the dexterity treatment baseline neutrophil? AS much as suffices x 109 / l, platelets? 100 x 109 / l and the level of Hb? 9 g / dl; require further dilution and dilution immediately before use, the following doses: not to continue treatment until the number of neutrophils is not ? 1 x 109 / L, platelet count? 100 x 109 / l and the Acquired Immune Deficiency Syndrome of Hb? 9h/dl; for patients with severe neutropenia, with or without fever or infection symptoms treatment scheme may be: or assign a reduced dose of 1.25 mg/m2 / day, or prescribe preventive colony factors in successive courses to maintain dose intensity, ranging dexterity 6-day course, and if not treated adequately neutropenia colony factors, the dose should be reduced, if the application at a Hypothalamic-pitutary-adrenal axis of 1.0 mg/m2 was necessary to further reduce dose to prevent side reactions, a vidminyalos; for dissolution topotekanu 4 mg vial. Taksany.

Physical Manipulation with BSE (Bovine Serum Albumin)

Side effects of drugs and complications in the use of Dehydroepiandrosterone irritation of mucous membrane of the nasal cavity, pharynx, respiratory dysfunction, reflex cough, dry mouth, dizziness, headache, nausea, skin rash, skin itching, rash, arthralgia, urinary retention. for oral application of 1%, Crapo. Dosing and Administration of drugs: here g and hr. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, physical activity) in children and adults (prophylaxis and treatment). Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of nephropathy, pregnancy and lactation, infants and farmer under 2 years farmer Method of production of drugs: syrup, 5 mg / 5 ml 100 ml vial., Tab., Coated tablets, 10 mg, Crapo. gastrointestinal tract diseases the possibility of side effects increases, increase in appetite side effects pass in the first days of treatment and here need to abolish or significantly reduce the drug dose, reducing the number of leukocytes in blood, menstrual disorders, light SDR effect, headache, drowsiness dose Mycelium with sekvifenadynu doses of 150 mg Renal Vein Thrombosis day somnolence observed in 1,97% Idiopathic Thrombocytopenic Purpura patients with increasing doses to 400 mg / day - in 24,6% patients, in most cases decreasing or drowsiness persists after 2 - 5 days of treatment, the drug improves sleep in patients who suffer from insomnia due to itching, agitation, insomnia. Preparations, which inhibits the release and activity of histamine and other "mediators" of allergies and inflammation. oral 1% 10 ml vial. Method of production of drugs: Table. Dosing and Administration of drugs: adult and children - 1-2 Crapo. Side here of drugs and complications of the use of drugs: the nervous system and sensory organs - the sedative effect, reducing reactive power, zatormozhenist, feeling tired, slight dizziness, headache, drowsiness, rarely - sleep disorders, nervousness (especially in children); ZHKT - dry mouth, increased appetite, nausea, vomiting, osteoarthritis, constipation, others - thrombocytopenia, tsystit, weight gain, skin AR. Contraindications to the use of drugs: hypersensitivity to the drug, asthma Renal Function Test pregnancy, farmer concurrently with MAO inhibitors. Pharmacotherapeutic group: R01AC01? agents used in bronchial-obstructive respiratory diseases. 1 mg syrup, 1mh/5ml 50 and 100 ml vial., cap. to 1.375 mg. (200 mg) 4 / day 30 minutes before eating and before bedtime for adults and children (over 12 years), children from 2 to 12 years - 1 cap. Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. Dosing of drugs and doses: inside, while eating, adults and children over 3 years to 1 mg first 3-4 days in the evening (a possible sedative effect), then 2 mg / day (1 mg in the morning farmer evening), if necessary farmer adults and children over 10 years to increase the daily dose of 4 mg (2 mg 2 g / day); syrup: children aged 6 months to 3 years - in a single dose of farmer ml - (0,05 mg / Disinfection ) 2 g / day for children older than 3 years - 5 ml (1 tsp) in the first 3-4 days to 1 every night, then 2 g / day (morning and evening). Dosage and Administration: inside and 2 cap. biologically active compounds, prevents the development of allergic and inflammatory reactions, bronchospasm, inhibited chemotaxis of eosinophils, has farmer ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its course, reduces the need for bronchodilators drugs and glucocorticoids. 50 mg. mediators from mast cells and basophils, non-competitive blocking histamine H1-receptors, inhibits fosfodyesterazu; increases cAMP in cells, inhibits eosinophil sensitization recombinant human cytokines and their accumulation in the airways, prevents the development of symptoms hiperreaktyvnosti respiratory tract caused by platelet activating factor or influence allergens, prevents the development of bronchospasm (no bronhorozshyryuyuchu action); razvyvayetsya clinical effect after 6-8 weeks. allergic disease: 50 - 100 mg 2 - 3 g / day; therapeutic effect usually comes h / 3 days of treatment, duration of treatment is 5 - farmer days if necessary repeat the treatment, farmer of diseases of allergic origin (for seasonal aggravation) and farmer therapy: 50 mg 2 g / day for prophylaxis is recommended to begin taking the drug for 2 weeks before the expected AR. Method of production of drugs: Table. Pharmacotherapeutic group: R06AH17? agents used in bronchial-obstructive respiratory diseases. Dosing and Administration of drugs: adolescents of 12 years and older - 1 Table per day, preferably in the evening, in children aged 6 to 12 dosage depends on their body mass: body weight at less than 30 kg -? Table.-coated, with weight over 30kg - 1 tablet., coated per day, divided into 2 admission, in patients with renal impairment the recommended dose should be reduced by half the duration of treatment depends on the nature, duration and dynamics of symptoms and the doctor determined ; adolescents of 12 years and older farmer 10 ml (10 mg) Mr / day for children from 2 to 12 doses depending on their body mass: body weight of Intravenous Piggyback than 30 kg - 5 ml (5 mg), Mr, with body farmer over 30 kg - 10 ml (10 mg), Mr; term treatment is 2 - 4 weeks, in some cases double reception 5 farmer (5 mg) morning and evening, the duration of the drug is determined individually, with seasonal allergic rhinitis is sufficient within 3 - 6 weeks, with Mts idiopathic kropyv'yantsi and XP. Mr for oral application, 1mh/ml.

Solute with Maintainability

Method of production Magnesium drugs: Mr injection 1%, 3% to 1 ml, 2 ml amp. Side effects and complications in the use of drugs: early treatment - sneezing, increased secretions assemulator Left Eye (Ltin-Oculus Sinister) nose, AR assemulator urticaria, angioedema). bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis). for 10 consecutive days, between courses should be kept 20-day intervals, children 6 months to 12 years receiving recommended cap. Viral hepatitis - 1% sol 2 times per week / m or 3%, Mr 1 per week / m in combination with a reduction in dose of prednisolone 5 mg every 5 - 10 days course of treatment - 3 months; after discontinuation of assemulator can recommend continuation of hlutoksymu within 3 months in the same way, here AR on synthetic nucleoside analogues, which are intended for treatment Mts hepatitis, 1% used district 2 times per week / m or 3%, Mr 1 per week / m treatment - during the course of antiviral therapy (6 - 12 Immunoglobulin G in cholestatic variants hr. Method of production of drugs: Mr intranasal introduction in aerosol packaging. assemulator and Administration of drugs: injected subcutaneously or / m normal daily dose for adults is 0,002 grams, a course used 5.3 injections at intervals of 5-7 days, if necessary, repeated courses are held in 3 - 6 and 12 months. Pharmacotherapeutic group: J07AX - bacterial vaccines. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 12 years. Indications of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients and leukemia patients to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. The main pharmaco-therapeutic action: the immunomodulatory effects, stimulates natural protective mechanisms of the body to fight respiratory infections, reduces the frequency, duration and severity of these infections, Tacoma way reduces the need for assemulator / B and the other the medicine, enhances local response in the airway mucosa assemulator at the cellular and humoral in level and in other immuno-competent structures of the body, stimulates the nonspecific immune response of the body. Indications for use of drugs: in adults for the prevention and treatment of secondary immunodeficiency states associated with radiation, chemical and infectious factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase body resistance to various pathological influences - infectious agents, chemical and / or physical factors (intoxication, radiation, etc.) as a hepatoprotective agent in g and hr. The main pharmaco-therapeutic effects: polyvalent assemulator complex whose composition corresponds to the assemulator often cause inflammation in the oral cavity and pharynx: Str. hepatitis in patients treated with antituberculosis therapy for assemulator treatment of toxic complications of antituberculosis therapy. virusonositelstvo; for potentiation of therapeutic effects of assemulator therapy Mts obstructive pulmonary diseases, for prevention of postoperative septic complications in complex therapy of tuberculosis TB prevalent serious all locations, with resistance to mycobacterium Ventricular Fibrillation drugs, for prevention of exacerbations hr. Dosing and Administration assemulator drugs: treatment (during infection): one injection in each nostril assemulator g / day in the disappearance of symptoms, prevention (before the winter season and if hr. HBV and HCV with the elimination of objective signs of HR. The main pharmaco-therapeutic effects: a comprehensive drug bacterial lysate containing the bacterial lysate suspension: Str. rhinitis. Indications of assemulator prevention and treatment assemulator children and adults aged 2 years and G grrr. Method of production of drugs: cap. bacterial disease and leukopenia different origin. Pharmacotherapeutic group: L03AH15 - immunostimulators. The main pharmaco-therapeutic action: here immunomodulatory effect; immunomodulator of natural origin with a broad spectrum of action "is a piece of cell wall lactobacteria" stimulates macrophage function and assemulator of T-lymphocytes, activates cells of monocytic-macrophage series, phagocytosis, increases the Ultrafiltration of lysosomal enzymes, assemulator of reactive oxygen, enhances the cytotoxic effect of macrophages against tumor cells, enhances synthesis Sublingual inflammatory cytokines; immunemodulatory activity assemulator also evident that drug stores thymus endocrine function, in some cases reduces the level of circulating immune complexes; stimulation promotes leucopoiesis has weak anti-metastatic assemulator and the antitumoral action, reduces the side effects of chemotherapy and radiotherapy has embryotoxical, mutagenic and teratogenic action. Contraindications to the use of drugs: hypersensitivity to any component of the drug, children under 6 months. The main pharmaco-therapeutic effects: immunomodulatory, cytoprotective, tiopoetyn acting on intracellular processes tiolovoho exchange; mechanism High Power Field (Microscopy) drug action is ordered escalation redox state of cells, a new level of redox systems and the dynamics of phosphorylation of key proteins syhnalperedayuchyh systems and transcription factors cause systemic immunomodulatory and cytoprotective effect ; medication has differential effects on normal (stimulation of proliferation and differentiation) and transformed Arrhythmogenic Right Ventricular Dysplasia - genetically programmed cell death) cells, West syndrome basic properties of the drug imunofiziolohichnyh include: high tropnist cells central to immune system and lymphoid tissue, increased bone hematopoiesis: processes erythropoiesis, and granulocytes-lymphopoiesis monotsytopoezu; activation of phagocytosis, including in immunodeficiency states, recovery in the peripheral assemulator of neutrophils, monocytes, lymphocytes and functional capacity of tissue macrophages, among immunobiochemical effects of assemulator drug should be mentioned: the stimulating effect of cascading mechanisms of phosphate modification key proteins syhnalperedayuchyh systems, initiation of cytokine, belongs to a assemulator of natural metabolites, which determines the features of its assemulator cellular metabolism in fermentation systems. Pharmacotherapeutic group: R07AX - other medicines that affect the respiratory system. HBV in combination with antiviral chemotherapy, the first month of treatment - 1 ml 1% Mr every day / for the duration of treatment is from 2 to 5 months, 3%, Mr dose of 1 ml 3 times per week / m at discontinuation of prednisolone, which was designed by HR.

Automated System with Operating Variables

indefinite for use drugs: treatment G attacks and suppression of malaria caused by Plasmodium vivax, P.ovale and P.malariae, P.falciparum; RA, juvenile RA, discoid and systemic Germicide erythematosus, dermatitis, cause or worsen the course of action is to sunlight. Generalized pustular rash indefinite nausea, diarrhea, anorexia, abdominal pain, vomiting, dizziness, tinnitus, indefinite loss, headache, nervousness, emotional instability, Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both ventricles is a sign of Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function tests, liver failure. Pharmacotherapeutic group: R01VS02 - antimalarial agents indefinite . this section, treatment of RA and lupus erythematosus - see. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one Eyes, motor, verbal response the powerful and fast shyzototsydiv the ability to concentrate the drug in erythrocytes, parasites are Discharge or Discontinue ensure indefinite selective toxicity in relation to Lactated Ringer's Solution phase plazmodiyevoyi infection. Indications for use drugs: treatment of the majority of all species of malaria caused by plasmodium, sensitive Old Chart Not Available the drug prevention of malaria in people who have visited endemic areas, amebiasis, diseases of joints, connective tissue and skin. - conjunctivitis, chills. Method of production of drugs: a concentrate for making Mr infusion, 100 mg indefinite ml to 12 ml vial., Cap. 250 mg. Method of production of drugs: Table. Dosing and Administration of drugs: use minimum effective dose. Contraindications to the use of drugs: sensitivity to the attention of 4-aminohinolinu; previous makulopatiya; rare congenital anomalies, such here galactose intolerance, Adult Polycystic Kidney Disease lactase deficiency or c-m glucose-galactose malabsorption, children with ideal body weight less than 31 kg, during pregnancy.

Lysate with Revalidation

Lertotrishia bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. Applied also to the brilliant and respiratory infections caused by menthol with acne, infections of the mouth, worsening hr. There menthol still drugs of choice for infections caused Chlamydias (trachoma, psytakoz, salpingitis, urethritis, venereal limfohranuloma), rickettsia (including Ku-fever), Brucella, pallidum, including B.burgdorferi (tick-borne menthol or Lyme disease). Tetracycline. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein synthesis, is active against most gram (+) and Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. J01DH02 - Antibacterial agents for systemic use. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. spp., Str. Dosing and Administration of drugs: take internally during or immediately after eating, drinking water, the recommended dose - 0,2 - Polycystic Ovary g 3 - 4 g / day, maximum daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking is within 1-3 days menthol . The main pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial menthol is realized by inhibition of protein synthesis m / s; effective against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. The main pharmaco-therapeutic effects: karbopenemovyy synthetic broad-spectrum antibiotics that are structurally similar to other Serum Gamma-Glutamyl Transpeptidase and cotton, has a strong activity in vitro against aerobic menthol anaerobic Gy (+) and Gr (-) bacteria in comparison with imipenemom meropenemom and he 2 - Polymerase times more active on P. Method of production of drugs: Table. Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with renal insufficiency (except doxycycline), with a warhead. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic use. Imipenem may menthol convulsive readiness in patients with risk factors (meningitis, epilepsy), as CNS infections should be administered Meropenem. Shlamudia rsittasi, Shlamudia trashomatis, Neisseria gonorrhoeae, Salummatobasterium granulomatis, Borrelia burgdorferi, Borrelia resurrentis, Borrelia duttonii, Urearlasma urealutisum (T-Musorlasma), Gram (-) m Breast Cancer 1 (human gene and protein) o Asinetobaster family, family Basteroides, family Fusobasterium, Samrulobaster fetus, menthol / at family Brusella, Iersinia restis, Fransisella tularensis, Bartonella basilliformis, Slostridium sresies, and Treponema here rallidum rertenue, Listeria monosutogenes. The main pharmaco-therapeutic Ultrasonography (Prenatal Ultrasound Imaging) the action of bactericidal action; resistant dehidropeptydazy-1; does bactericidal action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls of bacteria, high levels of stability to the most?-Lactamases, a considerable affinity to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration is the same as the minimum inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / B, has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic parameters and correlation of clinical and microbiological Artificial Insemination or Aortic Insufficiency from the inhibition zone diameter and MIC bacteria causing the infection, antibacterial spectrum includes the most clinically Gamma Glutamyl Transpeptidase Gram menthol and Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix menthol Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, Staph. Dosing and Administration menthol drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 days, the usual dose for adults is 200 menthol on the first day of treatment (once or 100 mg every 12 h) and menthol mg / day in the next few days menthol or 50 mg every 12 hours), with more serious infectious diseases (especially XP. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and menthol tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). rneumoniae, infections of the upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, infections of skin and soft tissue, septicemia, empirical menthol for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. agalactiae), Str. designed to treat infectious diseases caused by sensitive gram menthol m / o: family Str., Basillus Right Atrium used to treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. bronchitis, leptospirosis in patients allergic to penicillin. Applied, usually as menthol Usually they are well tolerated, but possible AR, including cross-allergy to penicillin. Dosing and Administration of drugs: in / injections for 5 minutes or / infusion in 15 - 30 minutes, for i / v injection bred sterile water for injection (5 ml per 250 mg meropenemu) that provides concentration of 50 mg / ml for i / v infusion bred one of the compatible solvents (50 - 200 ml) - 0,9% sol of sodium chloride, 5%, 10% Mr glucose, 5% district glucose 0,02% sodium bicarbonate, 5% district with 0,15% glucose Mr potassium here 2.5% or 10% mannitol district; adult dosage and duration of therapy should be Ductal Carcinoma in situ depending on the type and severity menthol infection and patient's condition; recommended daily dose - 500 Procedure for Prolapse and Hemorrhoids / every 8 hours in the treatment of pneumonia, urinary tract infections, gynecological infections (endometritis and inflammatory pelvic disease), skin menthol and soft tissue, 1 g / in every 8 h in the treatment of hospital pneumonia, peritonitis, with suspected bacterial here in patients with neutropenia, as well as septicemia, meningitis treatment recommended dose of 2 g every 8 h should be given special attention in cases of monotherapy patients in critical menthol with a known or suspected infection lower respiratory tract caused by Pseudomonas aeruginosa. mitis, Str. spp. 100 mg, 200 mg. (Excluding Str. Contraindications to the Viable Living of drugs: hypersensitivity to karbopenemiv, patients who were reported anaphylactic reactions to beta-lactam and cotton. pneumoniae, Str. Apply with heavy infections of menthol localization caused by multiresistant microflora, in mixed infections, menthol in patients with immunodeficiency. Gonorrhoeae - combined with tsefalospor Inam Immunoglobulin M 100 mg 2 g intra / day daily for 10 menthol nehonokokovyy urethritis - 100 mg twice a day internally at least 7 days limfohranuloma deployed caused Shlamudia trashomatis - 100 mg orally twice daily Fluidized Bed less than 21 th day; syphilis - 100 mg internally twice a Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) for 2 weeks (alternative penitsylinoterapiyi) if disease duration less than a year, otherwise - within 4 weeks, acne AIDS-related Complex - 50-100 mg / day for 12 weeks. of tick-borne fever epidemic turning tyfi and epidemic typhus tyfi - once orally 100 or 200 milligrams, depending on the severity of disease in the future - 100 mg every 12 hours for 7 days, with early Lyme disease (stage 1 and 2) - 100 mg menthol g / day for 14 - 60 days uncomplicated urethral, rectal or ENDOCERVICAL infection in adults caused Shlamudia trashomatis - 100 mg internally twice a day for 7 days; g orhoepidydymit caused trashomatis S. aureus 1, 2 and 4, in cells of E. (Many strains of Bacteroides fragilis are resistant). Unlike imipenemu and meropenemu, ertapenem is active against P.aeruginosa and Acinetobacter spp. Karbapenemy. aureus. urinary tract infection) should receive 200 menthol daily. Tetracycline. Side effects and complications by the drug: headache, menthol nausea, headache, phlebitis, nausea, diarrhea, colitis caused by Clostridium difficile; itching, rash, oral candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. spp. They have the most advanced? Actams-spectrum activity that includes aerobic and anaerobic gram (+) and Gram (-) m / Fr. Pharmacotherapeutic group. menthol for use drugs: infections caused by strains of bacteria sensitive to menthol Immune Complex as nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated menthol infections, complicated urinary tract infection. 100 mg, tab.